Monte Rosa Therapeutics, Inc. (GLUE) Ownership

$7.17

north_east
$0.06 (0.06%)
Day's range
$7.09
Day's range
$7.46

Monte Rosa Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEA MANAGEMENT COMPANY, LLC 11/14/2024 7.69 M $40.77 M   0.00% 9.38%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 6.60 M $34.99 M   10.43% 8.05%
AVORO CAPITAL ADVISORS LLC 11/14/2024 5.79 M $30.69 M   27.68% 7.06%
FMR LLC 11/13/2024 5.10 M $27.04 M   0.13% 6.22%
BAKER BROS. ADVISORS LP 11/14/2024 4.92 M $26.06 M   0.00% 5.99%
BLACKROCK FUNDING, INC. /DE 11/13/2024 2.90 M $15.38 M   100.00% 3.54%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2024 2.66 M $14.09 M   0.00% 3.24%
VANGUARD GROUP INC 11/13/2024 2.53 M $13.43 M   -0.50% 3.09%
AISLING CAPITAL MANAGEMENT LP 11/13/2024 1.47 M $7.80 M   0.00% 1.80%
ALPHABET INC. 11/08/2024 1.46 M $7.76 M   0.00% 1.79%
CITADEL ADVISORS LLC 11/14/2024 1.16 M $6.14 M   16.37% 1.41%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.04 M $5.54 M   23.28% 1.27%
VESTAL POINT CAPITAL, LP 11/14/2024 930,000 $4.93 M   4.49% 1.13%
STATE STREET CORP 11/14/2024 687,577 $3.64 M   8.10% 0.84%
PARKWOOD LLC 11/14/2024 426,620 $2.26 M   100.00% 0.52%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 393,586 $2.09 M   28.07% 0.48%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 346,498 $1.84 M   11.13% 0.42%
IKARIAN CAPITAL, LLC 11/14/2024 311,593 $1.65 M   100.00% 0.38%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 218,700 $1.16 M   -14.14% 0.27%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2024 217,001 $1.15 M   30.20% 0.26%
TD ASSET MANAGEMENT INC 11/01/2024 193,696 $1.00 M   0.00% 0.24%
GOLDMAN SACHS GROUP INC 11/14/2024 178,605 $946,606   93.40% 0.22%
MARSHALL WACE, LLP 11/14/2024 173,849 $921,400   100.00% 0.21%
BANK OF NEW YORK MELLON CORP 11/12/2024 166,693 $883,472   51.73% 0.20%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 139,273 $738,147   -9.42% 0.17%
MORGAN STANLEY 11/14/2024 125,332 $664,260   83.39% 0.15%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2024 118,103 $625,946   -68.51% 0.14%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 117,877 $624,748   14.77% 0.14%
ACADIAN ASSET MANAGEMENT LLC 11/12/2024 110,835 $586,000   12.46% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 102,835 $545,026   15.42% 0.13%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2024 91,292 $483,848   100.00% 0.11%
CASDIN CAPITAL, LLC 11/14/2024 86,014 $455,874   -67.05% 0.10%
BANK OF AMERICA CORP /DE/ 11/14/2024 73,419 $389,120   7.18% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 71,100 $376,830   -1.93% 0.09%
CITADEL ADVISORS LLC 11/14/2024 69,700 $369,410   495.73% 0.09%
AMERICAN CENTURY COMPANIES INC 11/12/2024 60,365 $319,935   22.17% 0.07%
BARCLAYS PLC 11/19/2024 54,508 $289,000   395.12% 0.07%
RHUMBLINE ADVISERS 11/12/2024 52,468 $278,070   9.48% 0.06%
LONG CORRIDOR ASSET MANAGEMENT LTD 11/12/2024 40,000 $212,000   0.00% 0.05%
HRT FINANCIAL LP 11/12/2024 38,911 $206,000   100.00% 0.05%
STATE OF WISCONSIN INVESTMENT BOARD 11/14/2024 36,300 $192,390   -20.22% 0.04%
ALLIANCEBERNSTEIN L.P. 11/14/2024 35,140 $186,242   7.20% 0.04%
ENTRYPOINT CAPITAL, LLC 11/13/2024 33,219 $176,061   100.00% 0.04%
CITADEL ADVISORS LLC 11/14/2024 31,200 $165,360   267.06% 0.04%
MILLENNIUM MANAGEMENT LLC 11/14/2024 30,621 $162,291   46.32% 0.04%
EXCHANGE TRADED CONCEPTS, LLC 10/10/2024 29,798 $157,929   -16.50% 0.04%
UBS GROUP AG 11/14/2024 25,333 $134,265   8.75% 0.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2024 25,000 $132,500   100.00% 0.03%
METLIFE INVESTMENT MANAGEMENT, LLC 11/13/2024 24,855 $131,732   100.00% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 22,617 $119,870   39.01% 0.03%

Monte Rosa Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of GLUE shares?

During the previous two years, 87 institutional investors and hedge funds held shares of Monte Rosa Therapeutics, Inc.. The most heavily invested institutionals were:

NEA Management Company, LLC: 7.69 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.6 M

Avoro Capital Advisors LLC: 5.79 M

FMR LLC: 5.1 M

BAKER BROS. ADVISORS LP: 4.92 M

BlackRock Funding, Inc. /DE: 2.9 M

What percentage of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors?

60.69% of Monte Rosa Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at GLUE ?

Institutional investors have bought a total of 51.73 M shares in the last 24 months. This purchase volume represents approximately $370.88 M in transactions.